Sana Biotechnology SANA
NASDAQ SANA
$2.33 -0.04 (-1.69%)
At close: Oct 23, 2026 · 4:00 PM EDT

Sana Biotechnology (SANA) Cash & Current Investments (2020 - 2026)

Updated

Sana Biotechnology's Cash & Current Investments was $160.49 million in Q2 2026, up 120.8% from $72.67 million a year earlier and up 58.7% from the prior quarter.

Analysis

Sana Biotechnology (SANA) Cash & Current Investments (2020 - 2026) Analysis & Trends

At the end of FY2025, Cash & Current Investments at Sana Biotechnology came in at $138.38 million, down 9.3% from FY2024.

  • Cash & Current Investments has now declined for four consecutive years, with a five-year compound annual growth rate of -18.2% (FY2020 to FY2025).
  • In earlier years, Cash & Current Investments was $152.5 million in FY2024 (-25.7%), $205.2 million in FY2023 (-51.6%), $423.96 million in FY2022 (-23.1%) and $551 million in FY2021 (+45.7%).
  • The Q2 2026 figure marks the highest quarterly Cash & Current Investments since Q3 2024.
  • Compared with a year earlier, Cash & Current Investments was higher in 1 of the last eight quarters, with an average decline of 13.0%.
  • The best year-over-year quarter for Cash & Current Investments over five years was Q2 2026 (growth of 120.8%); the worst was Q2 2025 (a decline of 71.1%).
  • Per Business Quant data, SANA's Cash & Current Investments in the three quarters before Q2 2026 was $101.14 million (Q1 2026), $138.38 million (Q4 2025) and $153.05 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 17.23 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn 6.57 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 7.69 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn 4.90 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 3.18 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 11.70 Bn
10 Sana Biotechnology 697.38 Mn 144.32 Mn - 160.49 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 160.49 Mn
Mar 31, 2026 101.14 Mn
Dec 31, 2025 138.38 Mn
Sep 30, 2025 153.05 Mn
Jun 30, 2025 72.67 Mn
Mar 31, 2025 104.70 Mn
Dec 31, 2024 152.50 Mn
Sep 30, 2024 199.01 Mn
Jun 30, 2024 251.64 Mn
Mar 31, 2024 311.08 Mn
Dec 31, 2023 205.20 Mn
Sep 30, 2023 268.57 Mn
Jun 30, 2023 325.92 Mn
Mar 31, 2023 349.31 Mn
Dec 31, 2022 423.96 Mn
Sep 30, 2022 485.75 Mn
Jun 30, 2022 484.80 Mn
Mar 31, 2022 512.38 Mn
Dec 31, 2021 551.00 Mn
Sep 30, 2021 603.71 Mn
API Access

Sana Biotechnology Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=SANA&period=max&api_key=YOUR_API_KEY